SML3644

JR-AB2-011

≥98% (HPLC)

• Sinônimo(s): 3-(3,4-Dichlorophenyl)-1-(4-fluorophenyl)-1-(5-methyl-4,5-dihydrothiazol-2-yl)urea, N-(3,4-Dichlorophenyl)-2-[(4-fluorophenyl)imino]-5-methyl-3-thiazolidinecarboxamide
• Fórmula empírica (Notação de Hill): C₁₇H₁₄Cl₂FN₃OS
• Número CAS: 2411853-34-2
• Peso molecular: 398.28
• Número MDL: MFCD32062799
• Código UNSPSC: 12352200
• NACRES: NA.77

Propriedades

• Nível de qualidade: 100
• Ensaio: ≥98% (HPLC)
• Formulário: powder
• cor: white to beige
• solubilidade: DMSO: 2 mg/mL, clear (Warmed)
• temperatura de armazenamento: 2-8°C

Descrição

Ações bioquímicas/fisiológicas

JR-AB2-011 is a selective mTORC2 inhibitor that blocks the interaction of Rictor and mTOR (IC50 = 0.31 µM) without affecing mTORC1 activity or assembly. JR-AB2-011 exhibits anti-glioblastoma (GBM) activity in vitro (proliferation IC50 = 0.31 µM post 72h treatment, 36.3% apoptosis post 48h 1 µM treatment in LN229 cultures) and in vivo (4 or 20 mg/kg/d i.p. to LN229 xenografted mice).

Selective mTORC2 inhibitor with anti-GBM efficacy in vitro and in vivo by blocking Rictor and mTOR interaction.

Informações de segurança

• Código de classe de armazenamento: 11 - Combustible Solids
• Classe de risco de água (WGK): WGK 3
• Ponto de fulgor (°F): Not applicable
• Ponto de fulgor (°C): Not applicable